Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
76,000
+300 (0.40%)
At close: Feb 27, 2026
43.40%
Market Cap 623.50B
Revenue (ttm) 14.90B
Net Income (ttm) -117.78M
Shares Out 8.20M
EPS (ttm) -606.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 64,370
Average Volume 101,745
Open 76,500
Previous Close 75,700
Day's Range 74,400 - 77,000
52-Week Range 35,600 - 101,000
Beta n/a
RSI 49.01
Earnings Date Mar 13, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.